G221 300 (Lithium 300 mg)
Pill imprint G221 300 has been identified as Lithium carbonate 300 mg.
Lithium is used in the treatment of bipolar disorder; borderline personality disorder; intermittent explosive disorder; depression; mania (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- G221 300
- Strength:
- 300 mg
- Color:
- Peach
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Glenmark Generics Inc.
- National Drug Code (NDC):
- 68462-0221
- Inactive Ingredients:
- FD&C Blue No. 1
FD&C Red No. 40
D&C Yellow No. 10
silicon dioxide
gelatin
sodium lauryl sulfate
magnesium silicate
titanium dioxide
shellac
propylene glycol
potassium hydroxide
ferrosoferric oxide
More about lithium
Consumer resources
- Lithium
- Lithium controlled-release and extended-release tablets
- Lithium syrup
- Lithium (Advanced Reading)
- Other brands: Lithobid, Eskalith, Eskalith-CR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
